Detalle de acción
MEDS
DataMEDS AI, Inc.
-
-
-
-
| Capitalización | - |
|---|---|
| Volumen | - |
| Rango del día | - |
| Ingresos (TTM) | - |
| Ingreso neto | - |
| EPS | - |
| Acciones en circulación | - |
| PE | - |
| PE forward | - |
| Dividendo | - |
| Fecha ex-dividendo | - |
| Open | - |
| Close anterior | - |
| Rango 52 semanas | - |
| Beta | - |
| Analistas | - |
| Precio objetivo | - |
| Fecha de resultados | - |
Cargando...
Acerca de
DataMEDS AI, Inc. operates as a health IT company in the United States.
The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers.
It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI.
It also operates as a pharmacy distributor; and provides clinical concierge services, . The company was formerly known as Wellgistics Health, Inc. and changed its name to DataMEDS AI, Inc. in July 2026.
DataMEDS AI, Inc. was incorporated in 2022 and is based in Tampa, Florida.
Industria
Minoristas farmacéuticos
Sector
Salud
Fecha de IPO
Feb 21, 2025
Empleados
-
Bolsa
NASDAQ
Sitio web
datamedsai.com
PUBLICIDAD